Investigation and Characterization of Clotting Artifacts in Coagulation Testing for the Development of Screening Criteria to Identify Clotted Plasma
International Journal of Laboratory Hematology · 2026-04 · 48 (2) · 384-391
DOI: 10.1111/ijlh.70019 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 25.10.2025. Verfasst von Jeong Hui Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan. Hauptthemen laut MEDLINE: Blood Coagulation, Artifacts. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Introduction
Coagulation tests are crucial for diagnosing hemostatic disorders. However, preanalytical errors, particularly sample clotting, may compromise test accuracy and lead to clinical misinterpretation. As not all clots are detectable by visual inspection, this study characterized clotted citrated samples to establish objective criteria for clot identification.
Methods
Routine coagulation assays—including PT, APTT, fibrinogen, D‐dimer, FDP, fibrin monomer complex (FMC), plasmin‐α2 plasmin inhibitor complex (PIC), and thrombin‐antithrombin complex (TAT)—were performed, and 101 paired specimens from 101 patients who required blood recollection were analyzed. Among the 77 specimens with visible clots, coagulation profiles were analyzed to identify cut‐off values and develop logistic regression models. The models were subsequently validated using an additional 24 abnormal but clot‐free specimens.
Results
Clotted samples showed significantly shortened APTT and elevated FDP, FMC, PIC, and TAT levels. Shortening of APTT by ≥ 3.1 s relative to the reference was a reliable indicator of clotting. Combining APTT with TAT or FMC provided high diagnostic accuracy (AUC: 0.969 and 1.000, respectively). We established a “Clotting Score” to assess sample viability even without visible clots. FDP and PIC increased progressively with time in clotted samples.
Conclusion
Sample clotting substantially affects the accuracy of coagulation tests. Shortened APTT and elevated FMC and TAT serve as reliable indicators, with FDP and PIC offering time‐sensitive supplementary clues. This multimodal approach could help standardize criteria for sample rejection and recollection, thereby improving test reliability and supporting clinical decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Nagoya University Hospital, Nagoya, Japan.
- Department of Clinical Laboratory, Kobe University Hospital, Kobe, Japan.
- Department of Transfusion Medicine, Nagoya University Hospital, Nagoya, Japan.
ORCID-Profile: Jeong Hui Kim, Atsuo Suzuki
Zitieren
APA
Kim, J. H., Suzuki, A., Kawakami, M., Hirotsu, M., Shirota, S., & Matsushita, T. (2026). Investigation and Characterization of Clotting Artifacts in Coagulation Testing for the Development of Screening Criteria to Identify Clotted Plasma. International Journal of Laboratory Hematology, 48(2), 384-391. https://doi.org/10.1111/ijlh.70019
Vancouver
Kim JH, Suzuki A, Kawakami M, Hirotsu M, Shirota S, Matsushita T. Investigation and Characterization of Clotting Artifacts in Coagulation Testing for the Development of Screening Criteria to Identify Clotted Plasma. International Journal of Laboratory Hematology. 2026;48(2):384-391. doi:10.1111/ijlh.70019
BibTeX
@article{Kim2026,
author = {Kim, Jeong Hui and Suzuki, Atsuo and Kawakami, Moe and Hirotsu, Mayuko and Shirota, Saki and Matsushita, Tadashi},
title = {Investigation and Characterization of Clotting Artifacts in Coagulation Testing for the Development of Screening Criteria to Identify Clotted Plasma},
journal = {International Journal of Laboratory Hematology},
year = {2026},
volume = {48},
number = {2},
pages = {384--391},
doi = {10.1111/ijlh.70019}
}
EUVIMED